Review: taking Amphetamine salt combo and Clonazepam together


Summary

Drug interactions are reported among people who take Amphetamine salt combo and Clonazepam together. This review analyzes the effectiveness and drug interactions between Amphetamine salt combo and Clonazepam. It is created by eHealthMe based on reports of 1,739 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Amphetamine salt combo and Clonazepam >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Amphetamine Salt Combo

Amphetamine salt combo has active ingredients of amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. It is often used in attention deficit hyperactivity disorder. (latest outcomes from Amphetamine salt combo 385 users)

Clonazepam

Clonazepam has active ingredients of clonazepam. It is often used in stress and anxiety. (latest outcomes from Clonazepam 45,597 users)

On Aug, 20, 2016

1,739 people who take Amphetamine Salt Combo, Clonazepam are studied.


Number of reports submitted per year:

Amphetamine salt combo and Clonazepam drug interactions.

Drug effectiveness over time:

Amphetamine Salt Combo:
  • < 1 month: 34.0% - (11 of 32 people)
  • 1 - 6 months: 58.0% - (50 of 86 people)
  • 6 - 12 months: 64.0% - (33 of 51 people)
  • 1 - 2 years: 46.0% - (36 of 77 people)
  • 2 - 5 years: 55.0% - (53 of 96 people)
  • 5 - 10 years: 67.0% - (31 of 46 people)
  • 10+ years: 75.0% - (22 of 29 people)
  • not specified: 75.0% - (3 of 4 people)
Clonazepam:
  • < 1 month: 40.0% - (13 of 32 people)
  • 1 - 6 months: 34.0% - (27 of 78 people)
  • 6 - 12 months: 45.0% - (22 of 48 people)
  • 1 - 2 years: 45.0% - (31 of 68 people)
  • 2 - 5 years: 57.0% - (54 of 94 people)
  • 5 - 10 years: 62.0% - (38 of 61 people)
  • 10+ years: 65.0% - (19 of 29 people)
  • not specified: 50.0% - (3 of 6 people)

Drug effectiveness by gender:

Amphetamine Salt Combo:
  • female: 56.0% - (160 of 284 people)
  • male: 57.0% - (79 of 137 people)
Clonazepam:
  • female: 48.0% - (135 of 281 people)
  • male: 53.0% - (72 of 135 people)

Drug effectiveness by age:

Amphetamine Salt Combo:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 100.0% - (1 of 1 people)
  • 10-19: 80.0% - (8 of 10 people)
  • 20-29: 62.0% - (73 of 116 people)
  • 30-39: 58.0% - (85 of 146 people)
  • 40-49: 50.0% - (43 of 86 people)
  • 50-59: 46.0% - (23 of 49 people)
  • 60+: 46.0% - (6 of 13 people)
Clonazepam:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 1 people)
  • 10-19: 27.0% - (3 of 11 people)
  • 20-29: 45.0% - (51 of 111 people)
  • 30-39: 53.0% - (77 of 144 people)
  • 40-49: 53.0% - (46 of 86 people)
  • 50-59: 51.0% - (25 of 49 people)
  • 60+: 35.0% - (5 of 14 people)

Most common drug interactions over time *:

< 1 month:
  • fatigue
  • depressed mood
  • aggression
  • somnolence
  • abnormal behaviour
  • convulsion
  • decreased appetite
  • delusion of grandeur
  • depression
  • drooling
1 - 6 months:
  • dry mouth
  • hot flashes
  • tremor
  • chills
  • death
  • aches and pains in bones
  • bowel movement irregularity
  • dry skin
  • dry throat
  • muscle aches
6 - 12 months:
  • abdominal pain
  • constipation
  • cholecystitis chronic
  • drug withdrawal syndrome neonatal
  • foetal exposure during pregnancy
  • gastrooesophageal reflux disease
  • muscular weakness
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • memory impairment
  • nausea
1 - 2 years:
  • sleep walking
  • insomnia
  • abdominal pain
  • urinary tract infection
  • aggression
  • anxiety disorder
  • depression
  • pregnancy - vaginal bleeding
  • agitation aggravated
  • breathing difficulty
2 - 5 years:
  • night sweats
  • stomach pain
  • weight gain
  • fatigue
  • constipation
  • hallucinations
  • nausea
  • panic attack
  • apathy
  • hair loss
5 - 10 years:
  • depression
  • nausea
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • fatigue
  • weight gain
  • dizziness (excl vertigo)
  • muscle twitching
  • muscle weakness
  • night sweats
  • anxiety
10+ years:
  • constipation
  • depression suicidal
  • anxiety disorder due to a general medical condition
  • attention deficit/hyperactivity disorder
  • chronic pain
  • congenital aortic stenosis
  • cough
  • depression
  • fatigue
  • fibromyalgia
not specified:
  • fatigue
  • anxiety
  • depression
  • nausea
  • insomnia
  • pain
  • headache
  • drug ineffective
  • fall
  • somnolence

Most common drug interactions by gender *:

female:
  • depression
  • nausea
  • fatigue
  • insomnia
  • pain
  • anxiety
  • headache
  • weight increased
  • drug ineffective
  • back pain
male:
  • anxiety
  • fatigue
  • insomnia
  • depression
  • drug abuse
  • nausea
  • aggression
  • drug ineffective
  • somnolence
  • agitation

Most common drug interactions by age *:

2-9:
  • decreased appetite
  • white blood cell count decreased
  • abnormal behaviour
  • aggression
  • convulsion
  • delusion of grandeur
  • depressed mood
  • drooling
  • malaise
  • penile infection
10-19:
  • cholecystitis chronic
  • pain
  • back pain
  • nausea
  • pain in extremity
  • vomiting
  • abdominal pain
  • aggression
  • calculus ureteric
  • crying
20-29:
  • anxiety
  • fatigue
  • nausea
  • depression
  • headache
  • dizziness
  • pain
  • weight decreased
  • insomnia
  • drug abuse
30-39:
  • sleep walking
  • depression
  • insomnia
  • nausea
  • weight increased
  • abdominal pain
  • aggression
  • mood altered
  • urinary tract infection
  • agitation aggravated
40-49:
  • fatigue
  • nausea
  • insomnia
  • depression
  • drug ineffective
  • headache
  • fall
  • pain
  • anxiety
  • tremor
50-59:
  • insomnia
  • depression
  • nausea
  • anxiety
  • fatigue
  • back pain
  • fall
  • somnolence
  • oedema peripheral
  • pain
60+:
  • depression
  • anxiety
  • nausea
  • completed suicide
  • insomnia
  • drug ineffective
  • diarrhoea
  • fatigue
  • pain
  • pain in extremity

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Amphetamine salt combo and Clonazepam?

Can you answer these questions?

More questions for: Amphetamine salt combo, Clonazepam

You may be interested in these reviews

More reviews for: Amphetamine salt combo, Clonazepam

On eHealthMe, Amphetamine salt combo (amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate) is often used to treat attention deficit hyperactivity disorder. Clonazepam (clonazepam) is often used to treat stress and anxiety. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.